An Open Label, Multi Centre, Phase II Study to Evaluate the Safety and Efficacy of Coramsine Injection in Patients with Renal Cell Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2016
At a glance
- Drugs SBP 002 (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- 30 Aug 2011 Actual initiation date (30 Jun 2006) added and official Title amended as reported by Australian New Zealand Clinical Trials Registry.
- 30 Aug 2011 New source identified and integrated (Australian New Zealand Clinical Trials Registry; ACTRN12606000099527).
- 16 Nov 2006 Status change